Platelet Activating Factor and Thromboxane B₂ Production After Cardiopulmonary Bypass

References

• Mangano D. T. Biventricular function after myocardial revascularization in humans: deterioration and recovery patterns during the first 24 hours. Anesthesiology 1985; 62: 571–577
   PubMed Web of Science ®Google Scholar
• Breisblatt W. M., Stein K. L., Wolfe C. J., et al. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol. 1990; 15: 1261–1269
   PubMed Web of Science ®Google Scholar
• Leung J. M., O'Kelly B. F., Mangano DT. Relationship of regional wall motion abnormalities to hemodynamic indices of myocardial oxygen supply and demand in patients undergoing CABG surgery. Anesthesiology 1990; 73: 802–814
   PubMed Web of Science ®Google Scholar
• Weintraub W. S., Jones E. L., Craver J., et al. Determinants of prolonged length of hospital stay after coronary bypass surgery. Circulation. 1989; 80: 276–284
   PubMed Web of Science ®Google Scholar
• Turnbull K. W., Miyagashima R. T., Gerein AN. Pulmonary complications and cardiopulmonary bypass: a clinical study in adults. Canad Anaesth Soc f. 1974; 21: 181–194
   PubMedGoogle Scholar
• Forman M. B., Virmani R., Puett DW. Mechanisms and therapy of myocardial reperfusion injury. Circulation. 1990; 81(IV)69–78
   Google Scholar
• McCord J. M. Oxygen-derived radicals: a link between reperfusion injury and inflammation. Federation Proc. 1987; 46: 2402–2406
   PubMedGoogle Scholar
• Benveniste J., Chignard M. A role for PAF-acether(platelet-activating factor) in platelet-dependent vascular diseases?. Circulation. 1985; 72: 713–717
   PubMed Web of Science ®Google Scholar
• Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol. 1990; 259: C697–C708
   PubMed Web of Science ®Google Scholar
• LeGall J. R., Brun-Buisson C., Trunet P., et al. Influence of age, previous health status, and severity of illness on outcome from intensive care. Crit Care Med. 1982; 10: 575–577
   PubMed Web of Science ®Google Scholar
• Montrucchio G., Alloatti G., Tetta C., et al. Release of platelet-activating factor from ischemic-reperfused rabbit heart. Am J Physiol. 1989; 256: H1236–H1246
   Google Scholar
• Maruyama M., Farber N. E., Vercellotti G. M., Jacob H. S., Gross GJ. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs. Am Heart J. 1990; 120: 510–520
   PubMed Web of Science ®Google Scholar
• McManus L. M., Pinckard RN. Kinetics of acetyl glyceryl ether phosphorylcholine(AGEPC)-induced acute lung alterations in the rabbit. Am J Pathol. 1985; 121: 55–68
   PubMed Web of Science ®Google Scholar
• Heffner J. E., Shoemaker S. A., Canham M., et al. Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. J Clin Invest. 1983; 71: 351–357
   PubMed Web of Science ®Google Scholar
• Shaw J. O., Picknard R. N., Ferrigni K. S., McManus L. M., Hanahan DJ. Activation of human neutrophils with 1-0-hexadecyl/octadecyl-2-acetylsn-glyceryl-3-phosphorylcho-line(platelet activating factor). J Immunol 1981; 127: 1250–1255
   PubMed Web of Science ®Google Scholar
• Qayumi A. K., Jamieson WRE, Poostizadeh A. Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation. Ann Thorac Surg. 1991; 52: 1026–1032
   PubMed Web of Science ®Google Scholar
• Taniguchi H., Iwasaka X., Takayama Y., Sugiura T., Inada M. Role of platelet-activating factor in pulmonary edema after coronary ligation in dogs. Chest. 1992; 102: 1245–1250
   PubMed Web of Science ®Google Scholar
• Chopra K., Singh M., Gupta S., Ganguly N. K. Involvement of oxygen free radicals in the action of BN 52021(PAF antagonist) to limit myocardial infarct size. Methods find Exp Clin Pharmacol. 1993; 15(7)437–445
   PubMedGoogle Scholar
• Hofer R. E., Christopherson T. J., Scheithauer B. W., Milde J. H., Lanier WL. The effect of a platelet activating factor antagonist(BN52021) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia. Anesthesiology 1993; 79: 347–353
   PubMed Web of Science ®Google Scholar
• May G. R., Paul W., Crook P., Butler K. D., Page CP. The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit. Br J Pharmacol. 1992; 106: 133–138
   PubMed Web of Science ®Google Scholar
• Zehr K. J., Poston R. S., Lee P. C., et al. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg. 1995; 59: 328–335
   PubMed Web of Science ®Google Scholar
• Butler J., Rocker G. M., Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993; 55: 552–559
   PubMed Web of Science ®Google Scholar
• Hoshikawa-Fujimura A. Y., Auler JO Junior, Da TR Rocha, et al. PAF-acether, superoxide anion and beta-glucuronidase as parameters of polymorphonuclear cell activation associated with cardiac surgery and cardiopulmonary bypass. Braz J Med Biol Res. 1989; 22(9)1077–1082
   PubMed Web of Science ®Google Scholar
• Nathan N., De nizot Y., Feiss P., Ladkar M., Arnoux B., Benveniste J. Variations of blood PAF-acether levels during coronary artery surgery. J Cardiothorac Vasc Anesth. 1992; 6: 692–696
   PubMedGoogle Scholar
• Kim Y. D., Danchak R. M., Heim K. F., Lees D. E., Myers AK. Constriction of canine coronary arteries by platelet activating factor after brief ischemia. Prostaglandins 1993; 46(3)269–276
   PubMed Web of Science ®Google Scholar
• Chen C-R, Voekel N. F., Chang S-W. Platelet-activating factro potentiates protamine-induced lung edema. Am J Respir Crit Care Med. 1994; 149: 34–40
   PubMed Web of Science ®Google Scholar
• Argiolas L., Fabidel F., Basso P. Mechanisms of pulmonary vasoconstriction and bronchoconstriction produced by PAF in the guinea-pig: role of platelets and cyclo-oxygenase metabolites. Br J Pharmacol. 1995; 114(1)203–209
   PubMed Web of Science ®Google Scholar
• Hennein H. A., Ebba H., Rodriguez J. L., et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg. 1994; 108: 626–635
   PubMed Web of Science ®Google Scholar
• Frering B., Philip I., De Houx M., et al. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1994; 108: 636–641
   PubMed Web of Science ®Google Scholar
• Squadrito F., Ioculano M., Altavilla D., et al. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury. J Lipid Med. 1993; 8(1)53–65
   PubMedGoogle Scholar